Yes, reduce your levothyroxine dose immediately
Your TSH of 0.16 mIU/L indicates you are overreplaced on levothyroxine 125 mcg daily and need a dose reduction to prevent adverse outcomes from subclinical hyperthyroidism.
Why This Matters
A TSH of 0.16 mIU/L falls well below the normal reference range (typically 0.3-0.45 mIU/L at the lower end), placing you in the category of subclinical hyperthyroidism. This is not benign—maintaining TSH levels outside the normal range increases mortality risk 1. Recent large population studies demonstrate that hypothyroid patients treated with levothyroxine have increased mortality when TSH is suppressed below or elevated above the normal reference range 1.
The specific risks of maintaining a suppressed TSH include:
- Atrial fibrillation (particularly concerning if you're older or have cardiac disease) 2
- Reduced bone mineral density and fracture risk 2
- Cardiac dysfunction 2
- Increased overall mortality 1
Recommended Action
Decrease your levothyroxine dose by 12.5 to 25 mcg (to either 112.5 mcg or 100 mcg daily) 3. The FDA labeling specifically recommends dose adjustments in increments of 12.5 to 25 mcg when TSH is abnormal 3.
Monitoring Schedule
- Recheck TSH in 6 to 8 weeks after the dose change 3
- The goal is to bring your TSH into the normal reference range (approximately 0.3-4.5 mIU/L for most adults)
- Once stable, monitor TSH every 6 to 12 months 3
Important Clinical Context
Age Considerations
If you are over 60 years old, this dose reduction is even more critical. TSH reference ranges are age-dependent—the upper limit of normal increases with age (up to 7.5 mIU/L for those over 80), but the lower limit remains around 0.3-0.4 mIU/L 4. Treatment of subclinical hyperthyroidism may be particularly harmful in elderly patients 4.
Cardiac Risk
If you have underlying cardiac disease or are at risk for atrial fibrillation, the urgency of dose reduction increases substantially. The guidelines note that patients with arrhythmias or cardiac disorders may not require aggressive TSH normalization if they feel well, but a TSH of 0.16 is sufficiently suppressed to warrant intervention regardless 2.
Dosage Stability
Patients on levothyroxine doses >125 mcg/day have a 2.4-fold increased risk of developing abnormal TSH values compared to those on lower doses 5. Since you're currently on 125 mcg, you're at the threshold where instability becomes more common, making regular monitoring essential.
Common Pitfalls to Avoid
- Don't wait to see if TSH "normalizes on its own"—you're on replacement therapy, so this represents overtreatment that requires intervention
- Don't make drastic dose changes—reduce by 12.5-25 mcg increments only 3
- Don't skip the 6-8 week recheck—this is the minimum time needed for TSH to equilibrate after a dose change 3
- Don't assume you feel fine so the TSH doesn't matter—subclinical hyperthyroidism causes harm even without overt symptoms 1
Special Circumstances
If you are pregnant or planning pregnancy, this becomes even more urgent. Pregnant women require TSH monitoring every 4 weeks with dose adjustments to maintain TSH in trimester-specific reference ranges 3. However, your current TSH suggests overreplacement rather than the increased requirements typical of pregnancy.
If you have thyroid cancer, different TSH targets apply based on your cancer stage and risk stratification—suppressed TSH may be intentional 3. Clarify this with your endocrinologist if applicable.
Bottom Line
Reduce your levothyroxine to 100-112.5 mcg daily and recheck TSH in 6-8 weeks. The evidence is clear that maintaining TSH outside the normal range—whether high or low—increases mortality and morbidity 1. Your current dose is excessive for your needs, and adjustment is both necessary and straightforward.